0001739815-18-000001.txt : 20180918 0001739815-18-000001.hdr.sgml : 20180918 20180918165259 ACCESSION NUMBER: 0001739815-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180918 DATE AS OF CHANGE: 20180918 EFFECTIVENESS DATE: 20180918 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fountain Therapeutics, Inc. CENTRAL INDEX KEY: 0001739815 IRS NUMBER: 824181770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-311831 FILM NUMBER: 181076244 BUSINESS ADDRESS: STREET 1: 1029 CATHCART WAY CITY: STANFORD STATE: CA ZIP: 94305 BUSINESS PHONE: 650-856-1971 MAIL ADDRESS: STREET 1: 1029 CATHCART WAY CITY: STANFORD STATE: CA ZIP: 94305 D/A 1 primary_doc.xml X0708 D/A LIVE 0001739815 Fountain Therapeutics, Inc. c/o MBCBioLabs 953 Indiana Street San Francisco CA CALIFORNIA 94107 650-856-1971 DELAWARE None None Corporation true 2018 Thomas A. Rando 1029 Cathcart Way Stanford CA CALIFORNIA 94305 Executive Officer Director Promoter Mr. Rando is the President, Treasurer, Secretary of the Issuer. Biotechnology Decline to Disclose 06b true 0001140361-18-022037 2018-05-04 false true true Series A Preferred Stock false 0 5000000 5000000 0 false 2 0 0 0 false Fountain Therapeutics, Inc. Thomas A. Rando Thomas A. Rando President of the Issuer 2018-09-12